
The results for 2014, which was Year 3 of the program, revealed winners and losers and showed that ACOs may not be the only solution to hold down the cost of healthcare.

The results for 2014, which was Year 3 of the program, revealed winners and losers and showed that ACOs may not be the only solution to hold down the cost of healthcare.

It's time to give the people what they want-real action to make pharmaceutical pricing more transparent, rational, and sustainable.

Republican presidential hopefuls may all be ready to repeal and replace the Affordable Care Act, but new reports in August found the health law continues to make big changes to the US healthcare system.

A trigger built in patient EHRs can avoid follow-up delays in those at risk for developing certain types of cancers, a JCO study shows.

Patients with type 1 diabetes mellitus have been advocating for Medicare to cover CGM technology, which they say is more important as patients age and symptoms of dropping blood sugar become less noticeable.

A recent study found that residents' PTSD is affected by the lack of social supports that existed even before the hurricane devastated the city on August 29, 2005. Depression, post-traumatic stress disorder, and other ailments are common, but psychiatrists and in-patient facilities are not.

Aetna and the University of Chicago Medicine kicked off a value-based oncology medical home model in July this year in an effort to transition from fee-for-service to value-based care.

The primary care doctor's involvement in a patient's weight-loss program can significantly improve patient outcomes, a study published in Patient Education & Counseling has found.

The study of Inuit adults found a correlation between cannabis use and lower BMI. The findings are consistent with other results reported this year.

Self-funded employee health benefits are becoming increasingly prevalent as employers seek ways to reduce healthcare expenses, increase plan flexibility, manage risk, and tailor plans to what their workers really want and need.

The National Comprehensive Cancer Network has announced the development of another "price" calculator that will help stakeholders assess the relative "value" of available options.

Governor Asa Hutchinson seeks changes to Arkansas' first-of-its-kind Medicaid expansion waiver, which may include workforce training requirements and higher out-of-pocket costs for those newly insured.

An analysis of data available on HealthCare.gov and 12 state-based exchanges while consumers shopped for plans found that sites should take more steps to better support consumers in making informed health plan decisions.

The top stories in managed care include results for patients with type 2 diabetes who were treated with high-dose liraglutide, challenges facing Medicaid managed care, and the rising popularity of doula services.

Alaska Governor Bill Walker (I) announced in July that he would expand Medicaid in his state despite the legislature's decision to block his efforts, and now the Republican-controlled body is suing him.

Since the first open enrollment period under the Affordable Care Act, enrollment in Medicaid has increased 21% and the program needs to be reinvented to keep up with future healthcare needs.

In a study that will surely set off alarms, Kansas researcher Kyle Chapman found that those with a college degree gain more benefits from good diets and exercise than those without the same education.

Enrollees on the public health insurance exchanges have shown themselves to be savvy, informed consumers, according to the results from the 2015 Survey of US Health Care Consumers report from the Deloitte Center for Health Solutions.

The study published in Science Translational Medicine found that tissue stiffening in the breasts of obese women can drive the development of malignant disease.

Governor Robert Bentley is calling out fellow Republicans in Alabama's legislature and asking what they would cut if they fail to pass his $300 million tax proposal. His state has some of the nation's highest rates of diabetes and obesity.

The incidence of hospitalizations for pulmonary hypertension among children has doubled from 1997 to 2012 with associated costs growing to $3.12 billion.

Results for the cardiovascular outcomes trial on the SGLT2 inhibitor mark the first time one of the newer diabetes drugs has produced benefits since the FDA began looking closely at these effects. Full data will be presented next month at the European Association for the Study of Diabetes.

Millions of exchange plan enrollees are missing out on subsidies available under the Affordable Care Act because they picked a non-qualifying health plan.

Conducted by researchers at the Memorial Sloan Kettering Cancer Center, phase 2 results from a basket trial evaluated the efficacy of vemurafenib on nonmelanoma BRaf V600-mutated cancers in 122 patients across 23 global centers.

Americans support more transparency in setting drug prices and letting Medicare negotiate with the pharmaceutical companies, according to the Kaiser Family Foundation poll.

The ITCA 650 device, which delivers tiny doses of exenatide, could be a game changer in solving the problem of medication adherence. An application for FDA approval is expected in the first half of 2016.

AJMC is proud to bring you the first in our series of educational webinars to help our readers and customers better understand some of the trends, challenges and opportunities in the managed care segment

As California reduced the number of adults ages 19 to 64 years without health insurance by 15.5% from 2013 to 2014, Medi-Cal enrollment among the same age group rose from 12.9% to 19.2% during the same time period, according to new data from the UCLA Center for Health Policy Research.

New York has a new law to protect consumers, and New Jersey and California are weighing similar legislation.

Winning bids reflect the trend of national insurers securing a large share of Medicaid managed care business as states seek savings and the Affordable Care Act allows for expansion.

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512
© 2025 MJH Life Sciences®
All rights reserved.
